Pfizer recalls millions of Nurtec ODT migraine drug packs over child poisoning risk and packaging flaw.

Pfizer is recalling over four million packages of Nurtec ODT prescription migraine medication due to a risk of poisoning to children as the packaging does not meet child-resistant packaging safety requirements. The medication was distributed at pharmacies nationwide from Dec. 2021 through March 2023. Consumers can obtain a free child-resistant pouch to store the product and pharmacists will place the blister packages into vials with child-resistant lids when filling patient prescriptions. No incidents have been reported in connection with the issue. Pfizer is working to create new packaging for the medication to comply with child-resistant packaging requirements.
- Pfizer recalls Nurtec ODT migraine prescription drug packs due to a risk of child poisoning NBC News
- Pfizer and Biohaven recall 4.2M Nurtec units on packaging flaw FiercePharma
- Pfizer recalls millions of migraine prescription drug packs due to a risk of child poisoning AOL
- Nurtec ODT recall: Pfizer to develop new packaging after product didn't meet child-resistant requirements Fox Business
- Pfizer recalls Nurtec ODT migraine therapy over packaging defect (NYSE:PFE) Seeking Alpha
Reading Insights
0
0
1 min
vs 2 min read
74%
379 → 97 words
Want the full story? Read the original article
Read on NBC News